Aryl hydrocarbon hydroxylase inducibility and bronchogenic carcinoma.
about
Multiple factors in carcinogenesisCrystalline silica is a negative modifier of pulmonary cytochrome P-4501A1 inductionIdentification of genetically high risk individuals to lung cancer by DNA polymorphisms of the cytochrome P450IA1 geneCancer risk assessment, indicators, and guidelines for polycyclic aromatic hydrocarbons in the ambient airHuman CYP1A1 gene: cosegregation of the enzyme inducibility phenotype and an RFLPThe relationship between aryl hydrocarbon hydroxylase and polymorphisms of the CYP1A1 geneCytochrome P-450 isozyme pattern is related to individual susceptibility to diethylnitrosamine-induced liver cancer in ratsAnimal models of human response to dioxinsFuture directions in epidemiologic studies of 1,3-butadiene-exposed workersCarcinogenicity of airborne fine particulate benzo(a)pyrene: an appraisal of the evidence and the need for controlGenetics of neoplasia--impact of ecogenetics on oncogenesis. A review.Contributions of human enzymes in carcinogen metabolismEpoxides--is there a human health problem?The physiological and pharmacological roles of cytochrome P450 isoenzymes.Polymorphisms of xenobiotic-metabolizing enzymes and susceptibility to cancerMolecular epidemiology: recent advances and future directions.Analysis of phenanthrene and benzo[a]pyrene tetraol enantiomers in human urine: relevance to the bay region diol epoxide hypothesis of benzo[a]pyrene carcinogenesis and to biomarker studies.Individuality in disease and therapy.Role of aryl hydrocarbon receptor-mediated induction of the CYP1 enzymes in environmental toxicity and cancer.Phenotyping cytochromes P450 with monoclonal antibodies.Metabolic activation of toxins: tissue-specific expression and metabolism in target organs.Biochemical studies of isolated hamster tracheal epithelium.Quantitation of a minor enantiomer of phenanthrene tetraol in human urine: correlations with levels of overall phenanthrene tetraol, benzo[a]pyrene tetraol, and 1-hydroxypyrene.Interaction of CYP1B1, cigarette-smoke carcinogen metabolism, and lung cancer risk.Carcinogen metabolism in human lung tissues and the effect of tobacco smoking: results from a case--control multicenter study on lung cancer patients.Polymorphism in CYP1A1 and CYP2D6 genes: possible association with susceptibility to lung cancer.Tobacco smoking, harm reduction, and biomarkers.Genetic differences in susceptibility to chemically induced myelotoxicity and leukemiaGenetic-environmental interactions in relation to low dose studies: a possible model from breast cancerAssignment of a locus required for flavoprotein-linked monooxygenase expression to human chromosome 2.Estimating cancer risks to a population.N-acetyltransferase phenotype and risk in urinary bladder cancer: approaches in molecular epidemiology. Preliminary results in Sweden and Denmark.Aryl hydrocarbon hydroxylase in cultured lymphocytes of twinsHuman P1-450 gene sequence and correlation of mRNA with genetic differences in benzo[a]pyrene metabolism.Cytochrome P450: what have we learned and what are the future issues?Heredity and human cancer.Sex differences and sex steroids in lung health and disease.The role of the pathologist in environmental medicine and public health3-methylindole-induced pulmonary injury in goats.Effect of transient expression of the oestrogen receptor on constitutive and inducible CYP1A1 in Hs578T human breast cancer cells
P2860
Q23912710-58DBC80D-995C-4FC4-B78B-986E60C30C5AQ23917114-EE37660E-ED5D-4B64-B6A7-8A2F520D2E2CQ24300296-F30633C8-531B-4D0C-BB20-2CF5761C7959Q24529932-3A818FAE-D250-4F4B-AE63-58EACCDEA277Q24679465-2D5F7BEE-6543-4F28-80CC-19986C42DF52Q28276614-0328B354-ED93-4A7B-86BF-D5E12FBEEEC9Q28326998-14493D8E-3B30-4D6D-ADBD-52EB8120A3B6Q28390140-9577473F-33CC-4854-8B84-E5C7CE028B03Q28390699-4D6D78A6-01D9-45E4-9A31-B14D065EC052Q28767704-4F03B04B-85FB-400C-BD88-4E3D64B7D96EQ30500345-165FDCBA-60A2-4E2E-AAE2-24EF538C7F59Q30520640-D241C93A-BF3D-4F16-9BF7-E9B16EB2108EQ33574878-1C16AACA-DCBB-48D7-9D64-7CD316B27D03Q33597477-E1227D4D-5CD9-45EC-9AD2-AE05C022201CQ33608783-75DA8F7A-43FE-47D1-8EEC-B37F28D81BF5Q33846244-10DF3521-38BC-4B13-8689-01A167AA24A9Q33857171-A6006113-C4DB-44E6-BACD-4270BABB1F1DQ34022128-A3B39207-B73C-42E6-AE00-74D6367FB97CQ34306783-E8D90DA9-4D40-42FC-B46E-93DEE3776D5FQ34322354-FF1D59DF-5F6C-4ABE-9B16-CAC6AFB894E7Q34638922-3C4E8A85-C679-43B0-A211-8E99455DF517Q34663831-5994468F-1031-499D-BD17-550DBF29FEC4Q34793024-BF39437D-6A50-4996-AD52-ABDF92D97258Q34793998-AC73627E-234B-4291-B055-EB7A6FD06030Q34843854-E502BAB2-91CA-4BE5-ADBC-794575834A82Q34857327-3BAFA786-E7A7-411F-8410-362F37E60763Q34931121-DAD1D859-31AB-4391-8514-2F0FB86C8CA1Q35035886-F153D469-78BF-411C-9448-611343957E69Q35036057-A829CC86-2A5C-4B11-BA42-23C7B8E3C896Q35044410-BD13B618-2B41-4E40-9B27-84E7ACBCA682Q35132342-999AAF3F-10F2-49A2-A35D-9792E92CE271Q35133059-1F56CB79-10B2-4E72-82AF-70AEF46694B0Q35202775-65EAEAF4-9634-43DC-9680-F7BE039B68EBQ35555377-04FD44D4-5503-4C37-AFFE-CF0520AB80B6Q35828009-B46D8040-1C73-4EAC-8B3E-E5D6251BD8CCQ35875051-1014B8AC-0DC4-4A79-A1EC-816AF1B11492Q36003356-C58D7449-891F-4B25-8E11-584A2A4FECE1Q36077015-EBEB621D-DCC6-4D78-9E66-FDFF8A196BE0Q36077148-B69658ED-26FA-4BE6-A0D1-FF6549BB7F3CQ36134987-ADAB8971-5C04-4FEE-A56E-DB82E4EF28F2
P2860
Aryl hydrocarbon hydroxylase inducibility and bronchogenic carcinoma.
description
1973 nî lūn-bûn
@nan
1973年の論文
@ja
1973年学术文章
@wuu
1973年学术文章
@zh-cn
1973年学术文章
@zh-hans
1973年学术文章
@zh-my
1973年学术文章
@zh-sg
1973年學術文章
@yue
1973年學術文章
@zh
1973年學術文章
@zh-hant
name
Aryl hydrocarbon hydroxylase inducibility and bronchogenic carcinoma.
@en
Aryl hydrocarbon hydroxylase inducibility and bronchogenic carcinoma.
@nl
type
label
Aryl hydrocarbon hydroxylase inducibility and bronchogenic carcinoma.
@en
Aryl hydrocarbon hydroxylase inducibility and bronchogenic carcinoma.
@nl
prefLabel
Aryl hydrocarbon hydroxylase inducibility and bronchogenic carcinoma.
@en
Aryl hydrocarbon hydroxylase inducibility and bronchogenic carcinoma.
@nl
P2093
P1476
Aryl hydrocarbon hydroxylase inducibility and bronchogenic carcinoma.
@en
P2093
Kellermann G
Luyten-Kellerman M
P304
P356
10.1056/NEJM197311012891802
P407
P577
1973-11-01T00:00:00Z